Information Journal Paper
APA:
CopyROSE, P.G., BLESSING, J.A., MAYER, A.R., & HOMESLEY, H.D.. (1998). PROLONGED ORAL ETOPOSIDE AS SECOND-LINE THERAPY FOR PLATINUM-RESISTANT AND PLATINUM-SENSITIVE OVARIAN CARCINOMA: A GYNECOLOGIC ONCOLOGY GROUP STUDY. JOURNAL OF CLINICAL ONCOLOGY, 16(2), 405-410. SID. https://sid.ir/paper/541186/en
Vancouver:
CopyROSE P.G., BLESSING J.A., MAYER A.R., HOMESLEY H.D.. PROLONGED ORAL ETOPOSIDE AS SECOND-LINE THERAPY FOR PLATINUM-RESISTANT AND PLATINUM-SENSITIVE OVARIAN CARCINOMA: A GYNECOLOGIC ONCOLOGY GROUP STUDY. JOURNAL OF CLINICAL ONCOLOGY[Internet]. 1998;16(2):405-410. Available from: https://sid.ir/paper/541186/en
IEEE:
CopyP.G. ROSE, J.A. BLESSING, A.R. MAYER, and H.D. HOMESLEY, “PROLONGED ORAL ETOPOSIDE AS SECOND-LINE THERAPY FOR PLATINUM-RESISTANT AND PLATINUM-SENSITIVE OVARIAN CARCINOMA: A GYNECOLOGIC ONCOLOGY GROUP STUDY,” JOURNAL OF CLINICAL ONCOLOGY, vol. 16, no. 2, pp. 405–410, 1998, [Online]. Available: https://sid.ir/paper/541186/en